Schizophrenia
Schizophrenic individuals have increased risk for sudden cardiac death
Young people with schizophrenia had elevated risk for sudden cardiac death, and biopsychosocial factors related to social isolation impacted the cardiac risk factor burden in individuals with schizophrenia, researchers reported.
Schizophrenia drug demonstrates efficacy, tolerability in phase 3 trial
KarXT was efficacious and safe in and well-tolerated by people with schizophrenia, according to a press release from its manufacturer.
Evenamide added to antipsychotic improves treatment-resistant schizophrenia
People with treatment-resistant schizophrenia experienced improvement with evenamide added to antipsychotics compared with antipsychotics alone, according to results from a 6-week trial.
Severe mental illness associated with breast cancer treatment disparities
Compared with other people with breast cancer, those with a preexisting severe mental illness were less likely to receive appropriate treatment and more likely to experience delays in receiving treatment, findings in Psycho-Oncology showed.
Motivational interview, CBT combination improves schizophrenia symptoms
Combining motivational interviews with cognitive behavioral therapy improved negative symptoms of schizophrenia compared with mindfulness sessions, according to findings published in The American Journal of Psychiatry.
Comorbid psychiatric, substance use disorders increase odds of COVID-19 hospitalization
Among patients with COVID-19 who visited EDs, those with both psychiatric and substance use disorders had greater odds of hospitalization compared with those with one or neither type of disorder, according to a study in JAMA Psychiatry.
Nonadherence, switching, stopping antipsychotics linked to more acute care utilization
For individuals prescribed antipsychotic medication, nonadherence, along with switching and stopping medication, was associated with increases in acute care utilization, according to a study published in BMC Psychiatry.
Impaired motor skills may indicate psychosis for kids in families with psych disorders
In children with familial high risk of schizophrenia or bipolar disorder, evidence of motor impairment skills may indicate neurodevelopmental vulnerability for psychosis.
Affordable Care Act provisions reduced percentage of uninsured people with schizophrenia
FDA approves schizophrenia, bipolar treatment
The FDA has approved Rykindo for extended-release injectable suspension for the treatment of schizophrenia, as well as monotherapy or adjunctive therapy for the maintenance treatment of bipolar 1 disorder in adults.